New Mexico Educational Retirement Board Has $7.03 Million Position in Danaher Co. (NYSE:DHR)

New Mexico Educational Retirement Board trimmed its position in Danaher Co. (NYSE:DHR - Free Report) by 5.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 30,635 shares of the conglomerate's stock after selling 1,600 shares during the quarter. New Mexico Educational Retirement Board's holdings in Danaher were worth $7,032,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of DHR. FMR LLC grew its position in shares of Danaher by 15.8% during the 3rd quarter. FMR LLC now owns 23,617,424 shares of the conglomerate's stock worth $6,566,116,000 after buying an additional 3,217,631 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Danaher by 3.0% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,097,986 shares of the conglomerate's stock valued at $1,417,342,000 after purchasing an additional 148,251 shares in the last quarter. Fisher Asset Management LLC raised its holdings in Danaher by 2.6% in the third quarter. Fisher Asset Management LLC now owns 4,552,640 shares of the conglomerate's stock worth $1,265,725,000 after purchasing an additional 116,299 shares during the period. Massachusetts Financial Services Co. MA increased its position in shares of Danaher by 17.6% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate's stock valued at $996,141,000 after buying an additional 535,254 shares in the last quarter. Finally, Montrusco Bolton Investments Inc. raised its stake in Danaher by 0.6% during the 4th quarter. Montrusco Bolton Investments Inc. now owns 1,715,826 shares of the conglomerate's stock worth $382,936,000 after buying an additional 9,942 shares during the period. 79.05% of the stock is owned by institutional investors.

Insider Buying and Selling at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 10.90% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the company. Barclays lowered their price target on Danaher from $275.00 to $240.00 and set an "equal weight" rating for the company in a report on Thursday, January 30th. UBS Group dropped their target price on shares of Danaher from $309.00 to $305.00 and set a "buy" rating on the stock in a report on Wednesday, October 23rd. Bank of America upgraded shares of Danaher from a "neutral" rating to a "buy" rating and set a $290.00 price target for the company in a report on Friday, December 13th. Scotiabank began coverage on shares of Danaher in a research report on Monday, December 23rd. They issued a "sector perform" rating and a $265.00 price objective on the stock. Finally, Citigroup lowered their target price on Danaher from $285.00 to $265.00 and set a "buy" rating for the company in a report on Thursday, January 30th. Seven investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $278.00.

Danaher Stock Performance

Shares of DHR stock traded up $0.70 on Wednesday, reaching $205.23. The stock had a trading volume of 4,572,680 shares, compared to its average volume of 4,519,168. The firm's 50-day moving average is $228.34 and its two-hundred day moving average is $248.10. Danaher Co. has a 12 month low of $196.80 and a 12 month high of $281.70. The firm has a market capitalization of $148.24 billion, a price-to-earnings ratio of 38.87, a P/E/G ratio of 2.63 and a beta of 0.83. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting analysts' consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter last year, the company earned $2.09 EPS. On average, research analysts expect that Danaher Co. will post 7.67 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were paid a dividend of $0.27 per share. The ex-dividend date was Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.53%. Danaher's payout ratio is 20.45%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.